- serotonin, dopamine, norepinephrine, epinephrine, and histamine. A
monoaminergic, or
monoaminergic drug, is a chemical,
which functions to
directly modulate the...
-
Monoaminergic activity enhancers (MAE), also
known as catecholaminergic/serotonergic
activity enhancers (CAE/SAE), are a
class of
drugs that
enhance the...
- serotonin–norepinephrine–dopamine
releasing agent (SNDRA).
Tryptamine is a
monoaminergic activity enhancer (MAE) of serotonin, norepinephrine, and
dopamine in...
- (MRIs) and
monoaminergic activity enhancers (MAEs),
which similarly increase synaptic monoamine neurotransmitter levels and
enhance monoaminergic signaling...
- Lisuride, sold
under the
brand name
Dopergin among others, is a
monoaminergic medication of the
ergoline family which is used in the
treatment of Parkinson's...
-
receptor 1 (TAAR1), a G-Coupled
Protein Receptor GPCR, to
regulate monoaminergic systems in the brain.
Active TAAR1
opposes the autoreceptor's activity...
-
classified as a tetrahydropyridine. It is of
interest as a
precursor to the
monoaminergic neurotoxin MPP+,
which causes permanent symptoms of Parkinson's disease...
-
monoamine neurotoxin, or
monoaminergic neurotoxin, is a drug that
selectively damages or
destroys monoaminergic neurons.
Monoaminergic neurons are neurons...
-
Besides the
preceding mechanisms,
haloperidol metabolizes into HPP+, a
monoaminergic neurotoxin related to MPTP. This
might be
involved in the extrapyramidal...
- code name V-111), also
known as 4-bromomethamphetamine (4-BMA), is a
monoaminergic drug of the
amphetamine family related to para-chloroamphetamine (PCA;...